Admixture dosing happens in genuinely small quantities that are easy to get wrong and hard to visually verify on site, which is exactly why dosage errors rank among the quality issues most likely to go completely undetected until strength testing eventually reveals a problem, often weeks after the concrete in question has already been placed.
| Error type | Typical cause | Typical effect on 28-day strength/performance |
|---|---|---|
| Under-dosed superplasticiser | Batching error, or compensating for a workability issue with water instead | Poor workability leading to inadequate compaction, indirect strength/durability loss |
| Over-dosed retarder | Miscalculation for transit time, or over-correction for hot weather conditions | Delayed setting time, potential strength development delay and formwork/schedule impact |
| Incorrect grout admixture dosage (for precast/post-tensioning grouting) | Batching or mixing error at point of use, often manual dosing without verification | Reduced grout strength or bleeding, directly affecting the structural connection's integrity |
Why Dosage Verification Needs to Happen at the Point of Use
A correctly designed admixture dosage documented in the original mix design paperwork doesn't guarantee correct dosage actually occurs at the batching plant or at the specific point of use - the real control points are batching plant calibration and, for site-applied admixtures, dosing pump verification, neither of which is automatically confirmed simply because the mix design document specifies the right number on paper. Grouting applications specifically - post-tensioning ducts, precast connection grouting - carry genuinely disproportionate risk from dosage errors, since grout's role here is structural connectivity rather than simple fill, giving a dosage error in this specific context a more direct structural consequence than an equivalent error in general concrete.
A Scenario Showing Why Fresh-State Monitoring Catches Problems Earlier
Picture a batching plant where superplasticiser dosing pump calibration drifts gradually over several weeks of continuous use without anyone specifically checking it, resulting in progressively under-dosed concrete that nobody notices until 28-day cube results from that period start coming back below specification. If the project team had been monitoring fresh concrete properties - slump consistency, setting time behaviour - as a routine practice throughout that period, the workability drift caused by declining superplasticiser dosage would likely have surfaced as an early warning signal considerably before the 28-day strength results eventually confirmed the underlying problem, giving the team weeks of earlier opportunity to catch and correct the calibration drift before it affected as much concrete.
Why Repeated Trial Batches Matter, Not Just an Initial One
Trial batches and dosage verification checks conducted at the start of a pour programme, and then repeated periodically throughout rather than assumed to hold consistently for the programme's entire duration, are what actually catch batching plant calibration drift before it affects a genuinely large quantity of concrete - a single trial batch verification at the very start of a long pour programme provides considerably less protection than the same verification repeated at reasonable intervals throughout.